ROYAL BANK OF CANADA – Edwards Lifesciences Corporation Transaction History
ROYAL BANK OF CANADA portfolio value:
$0
portfolio value
Edwards Lifesciences Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | put | Decrease | -100.00% | -165.4K shares | -15.72M | $82.63 | 0 |
Q3 2022 | share | Decrease | -8.21% | -434.00K shares | -101.75M | $82.63 | 4.85M |
Q2 2022 | share | Decrease | -13.61% | -833.15K shares | -217.75M | $95.09 | 5.28M |
Q2 2022 | put | Increase | 0.00% | 165.4K shares | 15.72M | $95.09 | 165.4K |
Q1 2022 | share | Decrease | -5.84% | -379.52K shares | -121.58M | $117.72 | 6.12M |
Q4 2021 | share | Decrease | -0.21% | -13.58K shares | 104.69M | $130.68 | 6.50M |
Q3 2021 | share | Decrease | -0.13% | -8.16K shares | 61.95M | $113.21 | 6.51M |
Q2 2021 | share | Increase | +7.34% | 445.78K shares | 167.28M | $103.57 | 6.52M |
Q1 2021 | share | Decrease | -0.01% | -697 shares | -46.19M | $83.64 | 6.07M |
Q4 2020 | share | Increase | +0.73% | 43.76K shares | 72.84M | $91.23 | 6.07M |
Q3 2020 | share | Increase | +15.84% | 825.01K shares | 121.64M | $79.82 | 6.03M |
Q2 2020 | share | Increase | +4.55% | 226.69K shares | 46.73M | $69.11 | 5.20M |
Q1 2020 | put | Decrease | -100.00% | -300 shares | -23K | $62.87 | 0 |
Q1 2020 | share | Increase | +12.20% | 541.93K shares | -32.04M | $62.87 | 4.98M |
Q4 2019 | share | Decrease | -8.90% | -433.95K shares | -12.00M | $77.76 | 4.44M |
Q4 2019 | put | Decrease | -98.88% | -26.4K shares | -1.93M | $77.76 | 300 |
Q3 2019 | put | Increase | 0.00% | 26.7K shares | 1.95M | $73.3 | 26.7K |
Q3 2019 | share | Decrease | -1.58% | -78.09K shares | 52.33M | $73.3 | 4.87M |
Q2 2019 | share | Increase | +7.17% | 331.49K shares | 10.26M | $61.58 | 4.95M |
Q1 2019 | share | Increase | +5.43% | 238.17K shares | 70.94M | $63.78 | 4.62M |
Q4 2018 | share | Decrease | -5.45% | -252.82K shares | -44.86M | $51.06 | 4.38M |
Q3 2018 | share | Increase | +2.89% | 130.11K shares | 50.01M | $58.03 | 4.63M |
Q2 2018 | share | Decrease | -3.13% | -145.56K shares | 2.31M | $48.52 | 4.50M |
Q1 2018 | share | Increase | +9.08% | 387.10K shares | 56.11M | $46.51 | 4.65M |
Q4 2017 | share | Increase | +7.43% | 294.83K shares | 15.57M | $37.57 | 4.26M |
Q3 2017 | share | Increase | +0.24% | 9.64K shares | -11.43M | $36.44 | 3.96M |
Q2 2017 | share | Increase | +0.68% | 26.83K shares | 32.74M | $39.41 | 3.95M |
Q1 2017 | share | Increase | +12.17% | 426.74K shares | 13.81M | $31.36 | 3.93M |
Q4 2016 | share | Increase | +1.86% | 64.00K shares | -28.81M | $31.23 | 3.50M |
Q3 2016 | share | Increase | +0.05% | 1.68K shares | 23.95M | $40.19 | 3.44M |
Q2 2016 | share | Decrease | -2.76% | -97.81K shares | 10.33M | $33.24 | 3.44M |
Q1 2016 | share | Increase | +4.58% | 154.85K shares | 14.96M | $29.4 | 3.53M |